The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis
Glucagon-like peptide-1 receptor agonists (GLP-1RA) have been reported to increase the risk of acute pancreatitis (AP). This real-world study did not observe a higher frequency of AP with GLP-1RA exposure in adults with T2D and a prior history of AP regardless of etiology.
Authors
- Alimitha M Kodali
- Yumiko Tsushima
- Laura D Lomeli
- Kevin M. Pantalone
- Adi Mehta
Institutions
- Cleveland Clinic (US)
- University Hospitals of Cleveland (US)
- Carolina Urologic Research Center (US)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1016/j.diabres.2024.111806
- Citations
- 23
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 8.23